caseins has been researched along with staurosporine aglycone in 1 studies
Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) | Studies (staurosporine aglycone) | Trials (staurosporine aglycone) | Recent Studies (post-2010) (staurosporine aglycone) |
---|---|---|---|---|---|
16,863 | 561 | 4,170 | 739 | 0 | 175 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Au, Q; Aza-Blanc, P; Boerries, M; Brabletz, T; Bronsert, P; Busch, H; Castro, DJ; Heynen-Genel, S; Kim, MM; Kuster, B; Maurer, J; Oshima, RG; Preca, BT; Stepputtis, SS; Stickeler, E; Strietz, J; Vannier, C | 1 |
1 other study(ies) available for caseins and staurosporine aglycone
Article | Year |
---|---|
ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer.
Topics: Animals; Antineoplastic Agents; Carbazoles; Caseins; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Endoribonucleases; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Indole Alkaloids; Keratin-5; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Phenotype; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; RNA Interference; Signal Transduction; Time Factors; Transfection; Triple Negative Breast Neoplasms; Tumor Burden | 2016 |